Biogen Inc. (NASDAQ: BIIB) has completed its acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company focused on central nervous system ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE